Trials / Not Yet Recruiting
Not Yet RecruitingNCT06939400
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
Study on Precision Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Zhejiang Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
GBM patients receiving PDT treatment (50 cases，surgery combined with photodynamic therapy) and traditional treatment (50 cases，traditional surgery) in our hospital and partner hospitals were collected. The prognosis was analyzed by comparing with the control group from multiple perspectives such as image evaluation, imaging effect, Karnofsky score, median survival time and survival rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Photodynamic therapy (PDT) | GBM patients recevied surgical combination photodynamic therapy |
| PROCEDURE | GBM patients recevied traditional treatment options | GBM patients recevied traditional treatment options (including surgery combined with radiotherapy and chemotherapy) |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2027-06-30
- Completion
- 2027-12-31
- First posted
- 2025-04-22
- Last updated
- 2025-04-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06939400. Inclusion in this directory is not an endorsement.